U.S., Jan. 14 -- ClinicalTrials.gov registry received information related to the study (NCT07336381) titled 'Replexa+ Shortwave Diathermy Device for Patients Diagnosed With Peripheral Artery Disease and Peripheral Neuropathy' on Jan. 11.
Brief Summary: This research project is designed to see if treatment with the Replexa+ shortwave diathermy device daily for 3 months will improve blood flow in the lower legs and feet of patients diagnosed with peripheral artery disease and peripheral neuropathy.
Study Start Date: Dec. 05, 2025
Study Type: INTERVENTIONAL
Condition:
Peripheral Arterial Disease
Peripheral Neuropathy
Intervention:
DEVICE: Replexa shortwave diathermy
Treatment with home use of the Replexa+ shortwave diathermy device twi...